All Cosmos Bio-Tech Holding Past Earnings Performance
Past criteria checks 2/6
All Cosmos Bio-Tech Holding has been growing earnings at an average annual rate of 19.6%, while the Chemicals industry saw earnings growing at 7.3% annually. Revenues have been growing at an average rate of 13.9% per year. All Cosmos Bio-Tech Holding's return on equity is 6.7%, and it has net margins of 4.9%.
Key information
19.6%
Earnings growth rate
19.6%
EPS growth rate
| Chemicals Industry Growth | 7.9% |
| Revenue growth rate | 13.9% |
| Return on equity | 6.7% |
| Net Margin | 4.9% |
| Next Earnings Update | 13 May 2024 |
Recent past performance updates
Recent updates
There May Be Reason For Hope In All Cosmos Bio-Tech Holding's (TWSE:4148) Disappointing Earnings
Mar 22
Is All Cosmos Bio-Tech Holding (TPE:4148) Using Too Much Debt?
Apr 20Returns On Capital At All Cosmos Bio-Tech Holding (TPE:4148) Paint An Interesting Picture
Jan 10
All Cosmos Bio-Tech Holding Corporation's (TPE:4148) Price Is Out Of Tune With Earnings
Dec 22Are Poor Financial Prospects Dragging Down All Cosmos Bio-Tech Holding Corporation (TPE:4148 Stock?
Dec 01Revenue & Expenses BreakdownBeta
How All Cosmos Bio-Tech Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,827 | 139 | 394 | 4 |
| 30 Sep 23 | 3,134 | 195 | 401 | 3 |
| 30 Jun 23 | 3,689 | 285 | 441 | 2 |
| 31 Mar 23 | 3,815 | 340 | 458 | 2 |
| 31 Dec 22 | 3,702 | 368 | 468 | 2 |
| 30 Sep 22 | 3,494 | 402 | 463 | 2 |
| 30 Jun 22 | 2,800 | 292 | 392 | 4 |
| 31 Mar 22 | 2,453 | 240 | 365 | 4 |
| 31 Dec 21 | 2,197 | 198 | 317 | 4 |
| 30 Sep 21 | 2,080 | 153 | 285 | 4 |
| 30 Jun 21 | 2,006 | 139 | 305 | 2 |
| 31 Mar 21 | 1,838 | 136 | 259 | 2 |
| 31 Dec 20 | 1,643 | 82 | 267 | 3 |
| 30 Sep 20 | 1,459 | 48 | 255 | 2 |
| 30 Jun 20 | 1,437 | 20 | 229 | 3 |
| 31 Mar 20 | 1,628 | 9 | 314 | 4 |
| 31 Dec 19 | 1,768 | 36 | 315 | 5 |
| 30 Sep 19 | 1,866 | 63 | 336 | 7 |
| 30 Jun 19 | 2,174 | 148 | 396 | 7 |
| 31 Mar 19 | 2,341 | 236 | 366 | 6 |
| 31 Dec 18 | 2,688 | 305 | 411 | 7 |
| 30 Sep 18 | 2,759 | 343 | 418 | 5 |
| 30 Jun 18 | 2,690 | 342 | 383 | 5 |
| 31 Mar 18 | 2,502 | 323 | 380 | 5 |
| 31 Dec 17 | 2,264 | 323 | 340 | 4 |
| 30 Sep 17 | 2,121 | 309 | 301 | 4 |
| 30 Jun 17 | 1,993 | 292 | 283 | 5 |
| 31 Mar 17 | 2,023 | 263 | 310 | 5 |
| 31 Dec 16 | 2,066 | 243 | 325 | 6 |
| 30 Sep 16 | 2,255 | 253 | 351 | 6 |
| 30 Jun 16 | 2,296 | 229 | 356 | 5 |
| 31 Mar 16 | 2,301 | 251 | 339 | 5 |
| 31 Dec 15 | 2,257 | 197 | 333 | 6 |
| 31 Dec 14 | 2,231 | 196 | 384 | 8 |
| 31 Dec 13 | 1,875 | 158 | 282 | 18 |
Quality Earnings: 4148 has high quality earnings.
Growing Profit Margin: 4148's current net profit margins (4.9%) are lower than last year (9.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4148's earnings have grown by 19.6% per year over the past 5 years.
Accelerating Growth: 4148's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4148 had negative earnings growth (-62.2%) over the past year, making it difficult to compare to the Chemicals industry average (-19.4%).
Return on Equity
High ROE: 4148's Return on Equity (6.7%) is considered low.